Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Sanara MedTech (SMTI) Capital Leases (2016)

Sanara MedTech's Capital Leases history spans 2 years, with the latest figure at $415.0 for Q3 2016.

For Q3 2016, Capital Leases changed N/A year-over-year to $415.0; the TTM value through Sep 2016 reached $415.0, changed N/A, while the annual FY2015 figure was $3973.0, N/A changed from the prior year.
Capital Leases reached $415.0 in Q3 2016 per SMTI's latest filing, down from $1609.0 in the prior quarter.
In the past five years, Capital Leases ranged from a high of $3973.0 in Q4 2015 to a low of $415.0 in Q3 2016.